S&P 500

6.071,17

0,53%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
Perspective Therapeutics Inc (CATX)
Perspective Therapeutics Inc (CATX) Notícias

CATX

Perspective Therapeutics (CATX)

Perspective Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:AMEX:CATX

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
24/01/2025	09:26	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CATX	Perspective Therapeutics Inc
24/01/2025	09:00	GlobeNewswire Inc.	Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium	AMEX:CATX	Perspective Therapeutics Inc
22/01/2025	09:00	GlobeNewswire Inc.	Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025	AMEX:CATX	Perspective Therapeutics Inc
13/01/2025	10:00	GlobeNewswire Inc.	Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference	AMEX:CATX	Perspective Therapeutics Inc
10/01/2025	09:00	GlobeNewswire Inc.	Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference	AMEX:CATX	Perspective Therapeutics Inc
07/01/2025	18:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CATX	Perspective Therapeutics Inc
07/01/2025	18:48	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:CATX	Perspective Therapeutics Inc
06/01/2025	10:00	GlobeNewswire Inc.	Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial Officer	AMEX:CATX	Perspective Therapeutics Inc
04/12/2024	19:17	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	AMEX:CATX	Perspective Therapeutics Inc
27/11/2024	09:00	GlobeNewswire Inc.	Perspective Therapeutics to Participate in Upcoming Investor Conferences in December	AMEX:CATX	Perspective Therapeutics Inc
21/11/2024	09:15	GlobeNewswire Inc.	Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium	AMEX:CATX	Perspective Therapeutics Inc
15/11/2024	18:08	GlobeNewswire Inc.	Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024	AMEX:CATX	Perspective Therapeutics Inc
14/11/2024	20:14	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	AMEX:CATX	Perspective Therapeutics Inc
14/11/2024	18:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	AMEX:CATX	Perspective Therapeutics Inc
12/11/2024	18:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:CATX	Perspective Therapeutics Inc
12/11/2024	18:05	GlobeNewswire Inc.	Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results	AMEX:CATX	Perspective Therapeutics Inc
31/10/2024	08:00	GlobeNewswire Inc.	Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results	AMEX:CATX	Perspective Therapeutics Inc
29/10/2024	08:00	GlobeNewswire Inc.	Perspective Therapeutics to Participate in Upcoming Investor Conferences in November	AMEX:CATX	Perspective Therapeutics Inc
23/10/2024	08:00	GlobeNewswire Inc.	Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine	AMEX:CATX	Perspective Therapeutics Inc
16/10/2024	08:00	GlobeNewswire Inc.	Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey	AMEX:CATX	Perspective Therapeutics Inc
11/10/2024	09:30	GlobeNewswire Inc.	Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research	AMEX:CATX	Perspective Therapeutics Inc
10/10/2024	18:14	GlobeNewswire Inc.	Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research	AMEX:CATX	Perspective Therapeutics Inc
07/10/2024	08:00	GlobeNewswire Inc.	Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day	AMEX:CATX	Perspective Therapeutics Inc
30/09/2024	08:00	GlobeNewswire Inc.	Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear Medicine	AMEX:CATX	Perspective Therapeutics Inc
10/09/2024	08:00	GlobeNewswire Inc.	Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024	AMEX:CATX	Perspective Therapeutics Inc
05/09/2024	08:00	GlobeNewswire Inc.	Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma	AMEX:CATX	Perspective Therapeutics Inc
28/08/2024	08:00	GlobeNewswire Inc.	Perspective Therapeutics to Participate in Upcoming Investor Conferences in September	AMEX:CATX	Perspective Therapeutics Inc
13/08/2024	06:39	IH Market News	Rumble Shares Up 7% in Premarket After 27% Q2 Revenue Surge; More on Earnings	AMEX:CATX	Perspective Therapeutics Inc
12/08/2024	17:05	GlobeNewswire Inc.	Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 2Q 2024 Results	AMEX:CATX	Perspective Therapeutics Inc
12/08/2024	06:47	IH Market News	U.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices Climb	AMEX:CATX	Perspective Therapeutics Inc